Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. North Dallas Honey
WARNING LETTER
•North Dallas Honey•January 15, 2013

FDA WARNING_LETTER - North Dallas Honey - January 15, 2013

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA inspected North Dallas Honey Company from September 2012 to January 2013, reviewing product labels for Nature Nate's Natural 100% Pure Raw & Unfiltered Honey, Nature Nate's North Dallas Honey Co. Pure Raw & Unfiltered Honey, and Norcal Honey Co. Pure Raw & Unfiltered Honey, along with the company's website, www.naturenates.com. The FDA concluded that the products are promoted for conditions that cause them to be unapproved new drugs under sections 201(g)(1)(B) and 201(p) of the Act, violating section 505(a). This was due to therapeutic claims on the Spanish website (e.g., for food poisoning, arthritis, allergy relief) and product labels (e.g., "Allergy relief"). Additionally, the products are misbranded foods. Nutrient content claims, such as "high in...antioxidants" on the Spanish website, do not comply with 21 CFR 101.54(g) regarding required nutrient naming. Implied "health benefits" claims on labels do not meet 21 CFR 101.65(d)(2) for using the term "health." Furthermore, Nature Nate's 100% North Dallas Honey Co. Pure Raw & Unfiltered Honey lacks required Nutrition Facts information per 21 CFR Part 101.9, and other products' Nutrition Facts panels are improperly formatted (21 CFR 101.9(d)(1)(i)). The company's October 2012 response was deemed inadequate as unlawful claims persisted. The FDA requires prompt corrective actions within fifteen working days to prevent further regulatory action.

Company
North Dallas Honey
Inspection Date
January 15, 2013
Product Type
Drugs
Office
Dallas District Office
Person
  • Reynaldo Rodriguez (District Director)
Open in Dashboard

ID · 72219ece-5db0-4b88-9264-e47999e021a6

Violation Codes10
21 U.S.C. 321(m)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 343(r)(1)(A)21 U.S.C. 343(r)(2)(A)(i)21 U.S.C. 343(q)21 U.S.C. 343(q)(5)(D)21 CFR 101.54(g)21 CFR 101.54(b)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.